Advion BioSciences Selects NoVa for New Lab
Advion BioSciences, based in Ithaca, N.Y., will now offer bioanalytical immunochemistry services in Manassas, Virginia. The decision to bring important discovery and the development of large molecule services to the fast growing macromolecule drug pipelines was made possible thanks to a wealth of skilled scientists and excellent existing laboratory space.
According to David Patteson, President and CEO of Advion BioSciences, “It has long been a desire to offer our clients these services and we are very pleased to have such skilled immunologists join our team.�
Tom Kurz, President of Advion BioServices went on to state: “The immunoassay service is a nice complement to our LC/MS/MS services and allows us to fully serve the bioanalytical needs for both small molecule drugs and biologics. Consistent with Advion’s reputation for scientific excellence and unparalleled service, we are committed to building an exceptional immunoassay service laboratory�.
Advion will provide a full range of ligand binding assays for the development and validation of traditional and custom designed ELISA’s, RIA’s, immunoassays, immunogenicity tests, multiplexed biomarker assays, cell based assays, and flow cytometry. Immunoassay services in support of development programs will be conducted under GLP conditions with the support of Advion’s existing infrastructure. All of Advion’s pre-existing quality and regulatory processes will be implemented at the Northern Virginia facility.
ÂÂ
